Showing results (191-200 of 777) with videos related to

Sort By:
Pageof 78
Blood|March 27, 2007
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cellsTanyel Kiziltepe, Teru Hideshima, Kenji Ishitsuka, et al.
British Journal of Haematology|April 22, 2016
A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cellsArghya Ray, Durgadevi Ravillah, Deepika S Das, et al.
British Journal of Haematology|December 1, 2010
PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivoAjita V Singh, Madhavi Bandi, Monette A Aujay, et al.
Leukemia|July 21, 2018
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivityJiye Liu, Tianyu Song, Wenrong Zhou, et al.
Blood|September 1, 2010
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myelomaDharminder Chauhan, Ajita V Singh, Monette Aujay, et al.
Cancer Research|October 16, 2003
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cellsMasaharu Akiyama, Teru Hideshima, Masood A Shammas, et al.
The Journal of Chemical Physics|October 5, 2013
Phase transitions in human IgG solutionsYing Wang, Aleksey Lomakin, Ramil F Latypov, et al.
Seminars in Oncology|October 19, 2013
Clinical translation in multiple myeloma: from bench to bedsideJacob Laubach, Teru Hideshima, Paul Richardson, et al.
Oncology (Williston Park, N.Y.)|August 29, 2007
Novel therapeutic avenues in myeloma: changing the treatment paradigmJoanne Ghobrial, Irene M Ghobrial, Constantine Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Pageof 78